OPUS GENETICS INC. - COMMON STOCK
1,1800
01-ноября-24 15:59:56
15 мин. задержка
Акции
-0,0200
-1,67%
Сегодняшний диапазон
1,1600 - 1,2185
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Ocuphire Presents APX3330 ZETA-1 Data at Clinical Trials at the Summit (CTS) 2023
12 июн 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24 май 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
15 май 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ASCRS 2023 and Eyecelerator
02 май 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs
25 апр 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer
21 апр 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
30 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ARVO 2023 Annual Meeting
23 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 Phase 2 Data Presentations at Retina Meetings
16 фев 2023 08:30:01 Источник Nasdaq GlobeNewswire
-
13 фев 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
25 янв 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
09 янв 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
06 дек 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire to Present at Five Upcoming Investor/Industry Conferences
21 ноя 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
07 ноя 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2022 and Provides Corporate Update
04 ноя 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
02 ноя 2022 08:09:57 Источник Nasdaq GlobeNewswire
-
24 окт 2022 08:56:52 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
07 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Hosting Key Opinion Leader Event on Oral APX3330 for Diabetic Eye Disease
06 окт 2022 09:27:49 Источник Nasdaq GlobeNewswire